Now, paying almost £1,200 to have an ADHD assessment feels remarkably similar to purchasing an airline fast-track pass—not because it is opulent, but rather because it gets you out of a seemingly never-ending line.
In the UK, private ADHD evaluations have changed over the past few years from being a specialized medical option to a surprisingly common financial choice that is discussed in group chats, in the kitchen, and discreetly over coffee between coworkers who are comparing wait times.
| Aspect | Typical Figures (UK, 2026) |
|---|---|
| Adult ADHD assessment | £950 to £1,300 on average |
| Child ADHD assessment | £1,000 to £1,700 |
| Lower-cost online options | From £249 to £399 |
| Follow-up appointments | £165 to £295 per session |
| Prescription admin fees | Around £75 to £80 |
| Medication costs | Paid separately |
| Combined ADHD + autism assessments | £1,145 to £2,800 |
| NHS shared care | Requires GP approval |
For adults, the average private assessment now sits between £950 and £1,300, with child assessments typically higher, reflecting the additional time, school reports, and family interviews required to reach a diagnosis that is considered clinically sound.
Lower‑cost providers have entered the space with assessments starting from £249, advertising speed and accessibility in a way that feels particularly innovative, yet these offers often cover only the initial diagnostic letter, leaving follow‑ups, prescriptions, and treatment planning as additional expenses.
In contrast, premium clinics bundle assessments with detailed reports, longer consultations, and post‑diagnosis guidance, creating a process that resembles a carefully guided pathway rather than a single appointment, though at a notably higher price.
Over the past decade, NHS ADHD waiting lists have grown so long that many patients stop asking how long it will take and instead ask whether it is still realistic to wait at all.
In some regions, people report being told the wait could stretch beyond two years, a timeframe that feels abstract until daily life starts fraying, with missed deadlines, emotional fatigue, and relationships quietly strained.
Demand has increased despite steadily rising costs because private clinics promise relief by operating remarkably quickly, frequently offering appointments within weeks or even days.
The experience itself varies widely.
Some assessments are exceptionally clear, involving long interviews, childhood history, questionnaires completed by partners or parents, and careful explanations of what ADHD is and what it is not.
Others are surprisingly brief, conducted over video calls that last under an hour, producing diagnoses that feel both validating and faintly unsettling, as though something deeply personal has been processed too quickly.
I found myself uneasy reading one account of a diagnosis delivered faster than a routine dental check‑up.
That unease reflects a wider tension in the private system, where efficiency is highly valued but depth can quietly erode if not deliberately protected.
Clinics defend their processes by pointing to national guidelines and standardized tools, and many clinicians genuinely aim to provide thoughtful care under intense demand.
However, the quality of assessment can feel as erratic as traffic patterns due to the lack of consistent oversight, particularly for new patients who lack a benchmark.
Costs rarely stop at diagnosis.
Follow‑up appointments, typically required for medication titration and monitoring, range from £165 to £295 per session, and most patients need several over the first few months.
Prescription administration fees, often around £75 to £80, add another layer, while medication costs themselves vary depending on the drug and dosage, sometimes quietly climbing into three‑figure monthly totals.
Over time, it is not unusual for patients to spend an additional £1,000 to £1,500 beyond the initial assessment, even before considering therapy, coaching, or workplace support.
Shared care agreements with NHS GPs offer a potential exit ramp, allowing prescriptions to be continued under public funding, but approval is not automatic and can feel frustratingly uncertain.
While some general practitioners (GPs) readily accept private diagnoses that clearly follow NICE guidelines, others ask for reassessments, thereby restarting the process that patients thought they had finished.
This uncertainty weighs heavily on families, particularly parents who have already paid for private child assessments and are trying to plan financially beyond the first year.
But optimism endures.
Awareness of ADHD has notably improved, driven by better education, open conversations, and more adults recognizing patterns that were previously dismissed as personal failings rather than neurological differences.
For many, a private assessment is not just a purchase but an investment in clarity, offering language, explanation, and tools that significantly improve daily functioning.
When done well, the process can be remarkably effective, helping individuals understand their strengths, manage their challenges, and advocate for adjustments at work or school with confidence.
The private ADHD sector in the UK is still evolving, shaped by demand, scrutiny, and growing calls for consistency.
In the coming years, pressure from patients, clinicians, and regulators may encourage higher standards across providers, making quality care both more reliable and, ideally, more affordable.
For the time being, individuals thinking about a private evaluation must make a choice that combines urgency with contemplation, healthcare with financial judgment, and hope with caution.
It is not an easy calculation, but for many, it represents a forward‑looking step toward understanding themselves better, even if the price tag still gives pause.